Augmedix, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q2 2024 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q3 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q4 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2025 | 1 | -$0.13 | -$0.13 | -$0.13 |
| Q2 2025 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q3 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
Augmedix, Inc. Earnings Date And Information
Augmedix, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.16 earnings per share for the quarter, missing analysts' consensus estimates of $-0.12 by $0.04. The company had revenue of 13.66 M for the quarter and had revenue of 44.86 M for the year. Augmedix, Inc. has generated $0 earnings per share over the last year ($-0.44 diluted earnings per share) and currently has a price-to-earnings ratio of -5.26. Augmedix, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 3rd, 2024 based on prior year's report dates.
Augmedix, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q2 2024 | -$0.12 | -$0.16 | -0.04 | $13.64 M | $13.66 M |
| 05/13/2024 | Q1 2024 | -$0.12 | -$0.12 | 0 | $13.47 M | |
| 04/29/2024 | Q4 2023 | -$0.09 | $12.68 M | |||
| 11/13/2023 | Q3 2023 | -$0.10 | $11.43 M | $11.77 M | ||
| 08/14/2023 | Q2 2023 | -$0.12 | $10.37 M | $10.78 M | ||
| 05/15/2023 | Q1 2023 | -$0.14 | $9.63 M | |||
| 04/28/2023 | Q4 2022 | -$0.15 | $8.75 M | |||
| 11/18/2022 | Q3 2022 | -$0.15 | -$0.15 | 0 | $7.76 M | $7.86 M |
| 08/11/2022 | Q2 2022 | -$0.24 | $7.33 M | $7.33 M | ||
| 05/12/2022 | Q1 2022 | -$0.16 | $6.99 M | |||
| 03/30/2022 | Q4 2021 | -$0.16 | $6.58 M | |||
| 11/09/2021 | Q3 2021 | -$0.10 | -$0.11 | -0.01 | $5.61 M | $5.63 M |
| 08/10/2021 | Q2 2021 | -$0.19 | -$0.17 | 0.02 | $5.18 M | $5.17 M |
| 05/17/2021 | Q1 2021 | -$0.18 | $4.79 M | |||
| 03/30/2021 | Q4 2020 | -$0.15 | $4.54 M | |||
| 09/29/2020 | Q3 2020 | -$0.15 | $4.25 M | |||
| 08/13/2020 | Q2 2020 | -$0.11 | $3.73 M | |||
| 05/15/2020 | Q1 2020 | -$0.18 | $3.97 M | |||
| 03/30/2020 | Q4 2019 | -$1.86 | $3.96 M | |||
| 11/13/2019 | Q3 2019 | -$3.35 | $3.67 M |
Augmedix, Inc. Earnings: Frequently Asked Questions
-
When is Augmedix, Inc.'s earnings date?
Augmedix, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 3rd, 2024 based off last year's report dates.
-
How can I listen to Augmedix, Inc.'s earnings conference call?
The conference call for Augmedix, Inc.'s latest earnings report can be listened to online.
-
How can I read Augmedix, Inc.'s conference call transcript?
The conference call transcript for Augmedix, Inc.'s latest earnings report can be read online.
-
How much revenue does Augmedix, Inc. generate each year?
Augmedix, Inc. (:AUGX) has a recorded annual revenue of $44.86 M.
-
How much profit does Augmedix, Inc. generate each year?
Augmedix, Inc. (:AUGX) has a recorded net income of $44.86 M. Augmedix, Inc. has generated $-0.44 earnings per share over the last four quarters.
-
What is Augmedix, Inc.'s price-to-earnings ratio?
Augmedix, Inc. (:AUGX) has a price-to-earnings ratio of -5.26 and price/earnings-to-growth ratio is 0.57.
